Smith; Graham F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Smith; Graham F..The latest application filed is for "inhibitors of irak4 activity".
- Smith; Graham F. - Sudbury MA
- SMITH; Graham F. - Boston MA US
| Patent | Date |
|---|---|
| Inhibitors of IRAK4 activity Grant 9,943,516 - Altman , et al. April 17, 2 | 2018-04-17 |
| Inhibitors of IRAK4 activity Grant 9,932,350 - Altman , et al. April 3, 2 | 2018-04-03 |
| Inhibitors of IRAK4 activity Grant 9,926,330 - Altman , et al. March 27, 2 | 2018-03-27 |
| Inhibitors Of Irak4 Activity App 20170275297 - ALTMAN; MICHAEL D. ; et al. | 2017-09-28 |
| Inhibitors Of Irak4 Activity App 20170247388 - ALTMAN; MICHAEL D. ; et al. | 2017-08-31 |
| Inhibitors Of Irak4 Activity App 20170217981 - ALTMAN; MICHAEL D. ; et al. | 2017-08-03 |
| Inhibitors Of Irak4 Activity App 20170209446 - ALTMAN; MICHAEL D. ; et al. | 2017-07-27 |
| Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors Grant 9,353,066 - Haidle , et al. May 31, 2 | 2016-05-31 |
| Compound Diversification Using Late Stage Functionalization App 20150274755 - Krska; Shane W. ; et al. | 2015-10-01 |
| Bipyridylaminopyridines as Syk inhibitors Grant 9,145,391 - Deschenes , et al. September 29, 2 | 2015-09-29 |
| Substituted Phenyl-spleen Tyrosine Kinase (syk) Inhibitors App 20150232428 - Haidle; Andrew M. ; et al. | 2015-08-20 |
| Bipyridylaminopyridines As Syk Inhibitors App 20140249130 - Deschenes; Denis ; et al. | 2014-09-04 |
| Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,604,038 - Edmondson , et al. December 10, 2 | 2013-12-10 |
| Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120225886 - Edmondson; Scott D. ; et al. | 2012-09-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 